Murali Ramanathan, State University of New York at Buffalo
Professor
Buffalo, New York
murali@buffalo.edu
Office:
(716) 645-4846
Expert In
Bio/Research
Murali Ramanathan can speak to the media about the physiological effects and pharmaceutical treatment of multiple sclerosis (MS), an inflammatory neurological disease affecting more than 2 million people worldwide.His research has found that cholesterol affects the progression of the disease. In ...
Click to Expand >>
Click to Expand >>
Bio/Research
Murali Ramanathan can speak to the media about the physiological effects and pharmaceutical treatment of multiple sclerosis (MS), an inflammatory neurological disease affecting more than 2 million people worldwide.His research has found that cholesterol affects the progression of the disease. In particular, he has found that LDL — or “bad” cholesterol — can adversely affect MS progression while HDL — “good” cholesterol — is protective against the breakdown of the blood-brain barrier in MS patients.His lab has investigated the mechanisms behind interferon-beta, a regularly used treatment for MS. He has also conducted research that indicates MS progresses more rapidly in African American patients than in Caucasian patients.Ramanathan’s current work focuses on how MS progression is affected by cholesterol and lipids, and by environmental and lifestyle factors such as smoking, vitamin D levels, and immune responses to the Epstein-Barr virus — the common cause for mono.
Click to Shrink <<
Click to Shrink <<